These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13711411)

  • 61. [Study of the bacteriostatic action in vitro of an erythromycin propionate-sulfonamide association on pathogenic staphylococci].
    MEYER J; KIEFFER L
    Rev Kuba Med Trop Parasitol; 1960; 24():633-6. PubMed ID: 24545883
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effects of the administration of sulfonamide by way of the exocrine ducts on the glycemia and histological structure of the pancreas].
    LOUBATIERES A; SASSINE A; MARIANI MM; FRUTEAU DE LACLOS C
    C R Seances Soc Biol Fil; 1960; 154():155-8. PubMed ID: 14418412
    [No Abstract]   [Full Text] [Related]  

  • 63. Some pharmacologic properties of sulfamethoxpyridazine and a new sulfonamide, sulfapyrazinemethoxyne, in calves.
    FAUSTINI R; VAGHI MA
    Am J Vet Res; 1962 Jan; 23():58-63. PubMed ID: 13891828
    [No Abstract]   [Full Text] [Related]  

  • 64. [Experiments of guinea-pigs sensitized with sulfonamide azoproteins].
    BRUN R; MUSSO E
    Int Arch Allergy Appl Immunol; 1961; 19():400-8. PubMed ID: 13873979
    [No Abstract]   [Full Text] [Related]  

  • 65. [Therapeutic value in determining the resistance of bacteria to antibiotics and sulfonamides].
    MEYER-ROHN J
    Arzneimittelforschung; 1953 Jul; 3(7):362-4. PubMed ID: 13081503
    [No Abstract]   [Full Text] [Related]  

  • 66. [SULFAMETHOXIDINE: EXPERIMENTAL AND CLINICAL EXPERIENCES WITH THE NEW CZECHOSLOVAKIAN SULFONAMIDE 2SULFANILAMIDO-5-METHOXYPYRIMIDINE].
    KRYL R; NEUBERTOVA E; BERANOVA Z
    Cas Lek Cesk; 1964 Apr; 103():366-73. PubMed ID: 14157627
    [No Abstract]   [Full Text] [Related]  

  • 67. [Experiences with the new sulfonamide powder "becarmal forte" (VEB Farbenfabrik Wolfen)].
    THORMER HJ
    Dtsch Gesundheitsw; 1959 May; 14():1014-7. PubMed ID: 13838194
    [No Abstract]   [Full Text] [Related]  

  • 68. [Methods and evaluation of determination of sulfonamide resistance by means of a modified plate tests in Listeria monocytogenes].
    LONZENMEIER G; SEELIGER H
    Z Hyg Infektionskr; 1953; 137(4):440-51. PubMed ID: 13137225
    [No Abstract]   [Full Text] [Related]  

  • 69. STUDIES OF SULFAMETHOXYDIAZINE. II. ANTIBACTERIAL ACTIVITY.
    KAPLAN K; CHEW WH; WEINSTEIN L
    Clin Pharmacol Ther; 1965; 6():316-20. PubMed ID: 14296029
    [No Abstract]   [Full Text] [Related]  

  • 70. [Pharmacological and clinical study, in the child, of a new sulfonamide with slow elimination].
    NUSSLE D
    Praxis; 1959 Aug; 48():733-44. PubMed ID: 14427944
    [No Abstract]   [Full Text] [Related]  

  • 71. [Bacteriostatic activity and pharmacodynamic properties of new sulfonamides].
    WALTER AM
    Antibiot Chemother; 1960; 8():54-82. PubMed ID: 13782938
    [No Abstract]   [Full Text] [Related]  

  • 72. [Studies on the cross resistance of bacteria to sulfonamides. 3. The behavior of bacteria toward sulfonamides substituted in N1 with an acyl, carbamyl, thiocarbamyl or guanidyl group].
    Patsch R; Höhne C
    Zentralbl Bakteriol Orig; 1967 Jan; 202(2):227-32. PubMed ID: 4970772
    [No Abstract]   [Full Text] [Related]  

  • 73. Determination of sulfonamide sensitivity with various culture media.
    VIRTANEN S
    Ann Med Exp Biol Fenn; 1952; 30(1):1-13. PubMed ID: 13008163
    [No Abstract]   [Full Text] [Related]  

  • 74. [On sulfonamide sensitivity of hemolytic streptococci in animal experiment and in vitro].
    SACKMANN W
    Pathol Microbiol (Basel); 1961; 24():768-73. PubMed ID: 14495866
    [No Abstract]   [Full Text] [Related]  

  • 75. [Experimental and clinical research on a new sulfonamide with depot properties: sulfamethoxydiazine].
    HITZENBERGER G; SPITZY KH
    Med Klin; 1962 Feb; 57():310-3. PubMed ID: 13907789
    [No Abstract]   [Full Text] [Related]  

  • 76. [Critical remarks on depot sulfonamide therapy after experiments on the lymphatic tonsillar ring].
    BECKMANN G; HOFMANN G
    Munch Med Wochenschr; 1960 Apr; 102():737-9. PubMed ID: 13798155
    [No Abstract]   [Full Text] [Related]  

  • 77. [Is the resistance against trimethoprim-sulfonamide increasing?].
    Bollgren I; Fogström B; Myrbäck CE
    Lakartidningen; 1991 Jan; 88(4):212. PubMed ID: 1994159
    [No Abstract]   [Full Text] [Related]  

  • 78. The relation of tryptophane utilization to the mechanism of resistance to sulfonamides.
    SEVAG MG; STEERS E
    Fed Proc; 1948 Mar; 7(1 Pt 1):310. PubMed ID: 18915962
    [No Abstract]   [Full Text] [Related]  

  • 79. Sulfonamide structure-activity relationships in a cell-free system. 2. Proof for the formation of a sulfonamide-containing folate analog.
    Bock L; Miller GH; Schaper KJ; Seydel JK
    J Med Chem; 1974 Jan; 17(1):23-8. PubMed ID: 4357096
    [No Abstract]   [Full Text] [Related]  

  • 80. [Bacteriological studies on the effect of sulfonamide preparations on dyspepsia coli strains].
    Freytag B
    Arzneimittelforschung; 1965 Mar; 15(3):294-7. PubMed ID: 5319134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.